Chinese Drugmaker Launches Epilepsy Medicine After Gov't Approval - Sixth Tone

1 year ago 37

A period aft China’s cause regulator approved a important medicine to dainty epilepsy successful children, its home shaper officially launched the cause Friday, which it claims to beryllium the lowest priced globally.

A generic mentation of Clobazam volition beryllium disposable astatine section pharmacies crossed the state for 84 yuan ($12) for a 28-tablet box, Sixth Tone’s sister publication, The Paper, reported Sunday, citing the president of Yichang Renfu Pharmaceutical Co. Ltd. China’s cause regulator had approved the cause connected Sept. 14.

Clobazam is effectual successful treating epilepsy, but has been classified arsenic a second-class psychotropic cause successful China, making it amerciable to merchantability and distribute. This has led to a thriving underground marketplace catering to parents desperately seeking to get the cause for their children.

Last year, a pistillate successful the cardinal Henan state was apprehended for “suspected smuggling, transportation, and cause trafficking” aft she received the cause from overseas and shared it with different idiosyncratic from an epilepsy enactment group. Prosecutors aboriginal dropped charges against the woman, whose kid besides suffers from epilepsy.

China’s apical wellness authorization said successful December that they planned to representation the colonisation of those successful request of the cause and signifier a centralized exertion process to conscionable patients’ needs. Months later, successful September, the National Health Commission approved Yichang Renfu Pharmaceutical Co. Ltd. to nutrient Clobazam locally.

Du Wentao, caput of Yichang Renfu Pharmaceutical, said during Friday’s motorboat that the domestically produced Clobazam was apt to beryllium included successful the country’s nationalist wellness security strategy successful 2023.

Editor: Bibek Bhandari.

(Header image: VCG)

Read Entire Article